Clinical trials
Cataract trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
220 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2004 | 1 |
| 2005 | 3 |
| 2006 | 1 |
| 2007 | 4 |
| 2008 | 5 |
| 2009 | 2 |
| 2010 | 3 |
| 2011 | 7 |
| 2012 | 5 |
| 2013 | 11 |
| 2014 | 6 |
| 2015 | 7 |
| 2016 | 11 |
| 2017 | 8 |
| 2018 | 20 |
| 2019 | 21 |
| 2020 | 18 |
| 2021 | 22 |
| 2022 | 30 |
| 2023 | 20 |
| 2024 | 12 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 220 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Vienna Institute for Research in Ocular Surgery | 17 |
| Prim. Prof. Dr. Oliver Findl, MBA | 11 |
| Sun Yat-sen University | 8 |
| Wenzhou Medical University | 8 |
| Guy's and St Thomas' NHS Foundation Trust | 5 |
| Uptown Eye Specialists | 4 |
| AST Products, Inc. | 3 |
| Aier School of Ophthalmology, Central South University | 3 |
| Assiut University | 3 |
| Eye & ENT Hospital of Fudan University | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cataract | 220 |
| Astigmatism | 18 |
| Glaucoma | 12 |
| Presbyopia | 8 |
| Dry Eye Syndromes | 6 |
| Pseudophakia | 6 |
| Eye Diseases | 5 |
| Corneal Diseases | 4 |
| Diabetic Retinopathy | 4 |
| Glaucoma, Open-Angle | 4 |
Trials
Showing 1 to 25 of 220. Each trial links to its page on Pharma Observatory.
120 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.